Singh Shomeshwar, Vashist Shashank, Ariyaratne Thathya V
The ENT Clinic, A7 Neeti Bagh, New Delhi, 110049, India.
Columbia Asia Hospital, Palam Vihar, Gurgaon, Haryana, India.
J Otol. 2015 Jun;10(2):57-65. doi: 10.1016/j.joto.2015.09.002. Epub 2015 Sep 30.
Currently, there is a significant lack of data concerning long-term outcomes following paediatric cochlear implantation in terms of quality of life. There is a need for a long-term, prospective study in this regard. This study aims at highlighting the preliminary results, one year post surgery of a five year prospective study.
The Cochlear™ Paediatric Implanted Recipient Observational Study (P-IROS) is a prospective, patient outcomes registry for routinely implanted children. The study collects data using questionnaires post-surgery and at regular intervals up to five years.
At our Centre, 159 cochlear implant surgery procedures were carried out between January 2014 and December 2014. Category of Auditory Performance II score increased from '0' to '3' at six months and to '5' at 12 months for children aged 0-3 years, although this was not statistically significant. However, the same trend was statistically significant for the age 3-6 year and age 6-10 year brackets. The quality of life of the child improved significantly. Analysis of communication mode revealed a statistically significant overall shift to the auditory-oral mode from total communication.
Cochlear implantation is a life-changing intervention. The evidence in support of what it can achieve safely is clear. However, the costs associated with it raise the question if it will remain an effective option for life in all children. The Cochlear P-IROS is an attempt to answer the same over a five year period. Our study in New Delhi, so far concludes that cochlear implantation in a population with limited access to funds is very effective, one year after surgery.
目前,关于小儿人工耳蜗植入术后长期生活质量的相关数据严重匮乏。因此,有必要开展一项长期的前瞻性研究。本研究旨在突出一项为期五年的前瞻性研究术后一年的初步结果。
人工耳蜗小儿植入受者观察性研究(P-IROS)是一项针对常规植入儿童的前瞻性患者结局登记研究。该研究通过术后问卷调查以及长达五年的定期随访来收集数据。
在我们中心,2014年1月至2014年12月期间共进行了159例人工耳蜗植入手术。0至3岁儿童的听觉表现II类评分在术后6个月时从“0”提高到“3”,12个月时提高到“5”,尽管差异无统计学意义。然而,在3至6岁和6至10岁年龄组中,相同趋势具有统计学意义。儿童的生活质量显著改善。对交流方式的分析显示,从全交流模式向听觉口语模式的总体转变具有统计学意义。
人工耳蜗植入是一项改变生活的干预措施。支持其能安全实现效果的证据确凿。然而,与之相关的成本引发了一个问题,即它是否仍将是所有儿童一生的有效选择。人工耳蜗P-IROS试图在五年内回答同样的问题。我们在新德里的研究目前得出结论,在资金获取有限的人群中,人工耳蜗植入术后一年非常有效。